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Background: Obstructive sleep apnea (OSA) is a relatively common disorder which has a 
negative impact on the psychological well-being of affected individuals.
Objective: To assess the association between OSA and depression as well as the effect of 
treatment with continuous positive airway pressure (CPAP).
Methods: A total of 37 newly diagnosed individuals with OSA underwent an overnight 
polysomnography and were assessed using the Epworth Sleepiness Scale (ESS), the Hamilton 
Depression Rating Scale (HDRS), and the Structured Clinical Interview for Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition. Patients were assessed before and after 
2 months of CPAP use.
Results: Of the 37 patients included in the study, 21 (56.7%) had clinically relevant depres-
sion as indicated by a score .10 on the HDRS and eleven patients (29.7%) met the diagnostic 
criteria for a major depressive episode using the Structured Clinical Interview. Scores on the 
HDRS were correlated with the Apnea Hypoxia Index, ESS scores, and oxygen saturation. 
Patients showed a significant reduction in depressive symptoms and improvement in ESS scores 
after CPAP treatment.
Conclusion: Patients with OSA should be screened carefully for depressive disorders. CPAP 
should be tried first before starting other treatment modalities for depression.
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Introduction
Obstructive sleep apnea (OSA) is by far the most common form of sleep-disordered 
breathing, and is defined as frequent episodes of obstructed breathing during sleep. 
Specifically, it is characterized by sleep-related decreases (hypopneas) or pauses 
(apneas) in respiration. An obstructive apnea is defined as at least a 10-second interrup-
tion of oronasal airflow, corresponding to a complete obstruction of the upper airways 
despite continuous chest and abdominal movements, and is associated with a decrease 
in oxygen saturation and/or arousals from sleep. It is confirmed by polysomnography 
recording determining an apnea-hypopnea index (AHI) of .5 per hour of sleep.1
The relation between OSA and depression has been the subject of many studies.2–5 
Most reported increased levels of depression in individuals with OSA.2,3 Studies that 
found an increased rate of depression in patients with OSA, also found that the prevalence 
of depression was variable; the rate was 17.6% using the Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria.4 When the research Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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diagnostic criteria for an affective disorder was used, the rate 
was around 40%,5 whereas Millman et al6 observed that 45% 
of their OSA patients had depressive symptoms on the Zung 
Self-Rating Depression Scale, and another study found that 
58% of individuals with OSA fulfilled the Diagnostic and 
Statistical Manual of Mental Disorders, Third Edition criteria 
for major depression.7 The use of different tools for diagnosing 
depression, with different criteria, cutoff points, and illness 
durations, may account for some of the variations in reported 
results in different studies.2–5 Alternatively, some studies 
found no such association.8–10 In addition, many patients with 
OSA are diagnosed as having a depressive disorder and many 
receive antidepressant medications before they are referred for 
assessment for sleep disorder.11 Thus, some researchers argue 
for a causal relation, with sleep fragmentation in OSA causing 
depression,12,13 others argue that a common neurobiological 
mechanism is the underlying cause for this association, with 
serotonin playing a central role,13,14 and yet another group claim 
that no clear relationship exists between the two disorders.15
Several studies attempted to delineate the relation between 
depression and components of OSA, either those observed 
clinically such as excessive daytime sleepiness16 or those 
components detected on polysomnography such as AHI,17,18 
oxygen saturation, and sleep stages15 and arousals detected 
by electroencephalogram (EEG). Results of those studies are 
quite variable with some studies finding correlations between 
some of the mentioned variables and depression, but others 
failing to find such an association.15–17 Still more research in 
this field is needed to adequately delineate the significance 
of such a relation.
The use of continuous positive air pressure (CPAP) is the 
treatment of choice for OSA. However, studies to date on 
its effect on depressive symptoms have yielded inconsistent 
  findings. Most of the studies reported a positive effect of CPAP 
on the psychological well-being of individuals treated in this 
way,6,19,20 while others reported no such improvement.21,22
The use of CPAP is the treatment of choice for OSA. 
However, studies to date on its effect on depressive symptoms 
have yielded inconsistent findings.
Objective
In this study, it was aimed to determine the rate of depression 
associated with OSA, and to study the effect of CPAP on the 
psychological condition of these patients.
Methods
Individuals were recruited from the sleep laboratory of 
the Hospital of Bahrain. All patients who met the standard 
  indications for polysomnographic evaluation for the suspected 
diagnosis of OSA were eligible for entry into the study. The 
local ethics committee approved the study and patients who 
agreed to participate in the study gave informed consent. 
Patients with a previous psychiatric diagnosis or who were 
on antidepressant medications were excluded from the study. 
Patients with chronic diseases (respiratory, renal, cardiac, 
neurological, and hepatic disorders) were also excluded.
All patients underwent overnight polysomnography using 
the Alice® 5 Polysomnography System (Philips Respiron-
ics, Murraysville, PA) with Alice Sleepware   Software. This 
polysomnogram consisted of overnight recording of left 
and right electrooculogram, chin electromyogram, left and 
right tibialis anterior electromyogram, central and occipital 
EEG, electrocardiogram, airflow measurement, body posi-
tion sensor, snoring sensor and microphone, respiratory 
effort belt (abdominal and thoracic), and pulse oximetry. 
The sleep study began around 11 pm and the duration of 
the study was at least 5 hours. The patients were instructed 
to avoid sleeping during the daytime before the study and 
to avoid alcohol, sedatives, hypnotics, and other medicines 
affecting sleep.
Patients with OSA were interviewed and assessed using 
three tools.
1.  The Epworth Sleepiness Scale was used to assess daytime 
sleepiness. Patients rated the likelihood of falling asleep in 
eight specific situations on a 0–3 scale, with 0 meaning no 
chance at all of falling asleep, and 3 representing a high 
chance of falling asleep. Thus, the scale goes from 0 to 24. 
A score of ten suggests excessive daytime sleepiness.23
2.  The Hamilton Depression Rating Scale (HDRS) is an 
inventory employed to detect and identify the intensity 
or severity of the signs and symptoms of   depression;   
17   questions are divided into two categories. The first 
category consists of nine questions scored on a five-point 
scale; the second category consists of eight questions rated 
on a three-point scale. A total score is computed reflecting 
the degree of symptom severity. A score .10 indicates 
impairment.24
3.  The Structured Clinical Interview for DSM-IV (SCID) 
is a semistructured interview used to establish the major 
Axis I diagnoses in DSM-IV . It is administered by a clini-
cian and includes an introductory overview followed by 
nine modules, seven of which represent the major Axis I 
diagnostic classes. Only the section on mood disorders 
was used.25
Patients were assessed twice: a baseline was done imme-
diately after the sleep study and confirmation of the presence Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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of OSA, and a second assessment was completed 2 months 
after treatment with the CPAP. Polysomnography was done 
and interpreted by both the pulmonologist and neurologist, 
and the psychiatrist was blinded to the severity of sleep dis-
turbance while conducting psychiatric assessment.
Data were analyzed using SPSS (v 15.0; IBM Corp, 
Armonk, NY). Means with standard deviations or percent-
ages were used to describe the sample. Group differences 
were assessed with unpaired t-tests and the changes after 
treatment were assessed with paired t-tests. Comparison for 
categorical variables was done using the chi-square test. The 
Pearson linear correlation was also determined between cer-
tain variables. A P value , 0.05 was considered to indicate 
statistical significance.
Results
From June 2010 to December 2010, 44 patients were diag-
nosed with OSA and were eligible to be included in the study. 
Seven patients were excluded from the study: two refused 
to contribute in the study, two had a previous psychiatric 
diagnosis, two refused treatment with CPAP, and one was 
not compliant with CPAP. The remaining 37 patients were 
included in the study.
The mean age of individuals was 44.9 ± 8.8; there was no 
statistical difference between males and females as regards 
the age. Twenty-one individuals had HDRS scores above 
the cut-off point of the scale of ten (indicating some sort 
of depression), 13 individuals (35.1%) had mild depressive 
symptoms while four had moderate symptoms (10.8%), and 
the same number had severe symptoms. It is important to 
note that the levels of depressive symptoms obtained from 
the Hamilton scale are a continuous measure of depressive 
symptoms and do not necessarily always equate with a for-
mal categorical diagnosis of major depressive disorder. The 
mean total score of the HDRS was 11.5 ± 9.6, females had 
statistically significant higher scores than males (P = 0.049). 
Using the SCID, eleven patients fulfilled the clinical criteria 
of a major depressive disorder according to DSM-IV , seven 
with mild and four with moderate depressive episodes. The 
mean ESS was 11.6 ± 8.6 while the mean AHI was 27.7 ± 7.3; 
there was no statistically significant difference between males 
and females on either parameter. The mean arousal index was 
33.4 ± 5.5 as indicated by EEG analysis of the sleep stages 
and there was no statistically significant difference between 
males and females. The lowest oxygen saturation (SaO2) 
during the sleep study showed a mean of 67.5% ± 3% and 
there was no statistically significant difference between males 
and females (Table 1).
The age of the patient correlated positively with AHI 
(P = 0.000), and ESS (P = 0.02) and lowest oxygen satura-
tion (P = 0.048). There was a significant negative correla-
tion between the lowest oxygen saturation and HDRS score 
(P = 0.000). ESS was correlated positively with the HDRS 
(P = 0.000) and so was the AHI (P = 0.000) (Table 2).
There was a statistically significant decrease in the HDRS 
in all groups when patients with OSA used the CPAP for 
2 months (Table 3). Six of the eleven patients previously 
diagnosed with a depressive episode by the SCID prior to 
Table 1 Patient’s description on first examination
Males (N = 24) Females (N = 13) Total (N = 37) Difference
Age Mean = 45.3 ± 9.2 Mean = 44.2 ± 8.3 Mean = 44.9 ± 8.8 t = 0.3, P = 0.7
hDrS 
  Normal (0–9) 
  Mild (10–13) 
  Moderate (14–7) 
  Severe (.17) 
  Total score
 
12 (50%) 
8 (33.3%) 
2 (8.3%) 
2 (8.3%) 
Mean = 9.3 ± 7.5
 
4 (30.8%) 
5 (38.5) 
2 (15.4%) 
2 (15.4%) 
Mean = 15.6 ± 9.8
 
16 (43.3%) 
13 (35.1) 
4 (10.8) 
4 (10.8%) 
Mean = 11.5 ± 9.6
 
chi-square = 1.7, P = 0.7 
 
 
 
t = 2.1, DF 35, P = 0.049*
SciD 
  No disorder 
  Mild depressiona 
  Mod depressionb
 
18 (75%) 
4 (16.7%) 
2 (8.4%)
 
8 (61%) 
3 (23%) 
2 (15%)
 
26 (70.3) 
7 (18.9%) 
4 (10.8)
chi-square = 0.8, P = 0.7
ESS Mean = 10.9 ± 7.5 Mean = 13.1 ± 9.8 Mean = 11.6 ± 8.6 t = 0.26, P = 0.1
Ahi Mean = 28.2 ± 6.9 Mean = 26.9 ± 8.2 Mean = 27.7 ± 7.3 t = 0.5, DF 35, P = 0.6
Lowest O2 saturation (SaO2) Mean = 67.2 ± 2.8 Mean = 67.6 ± 3.3 Mean = 67.5 ± 3 t = 0.3, DF 35, P = 0.7
Arousal index Mean = 33.8 ± 4.8 Mean = 32.7 ± 6.9 Mean = 33.45 ± 5.5 t = 0.5, DF 35, P = 0.6
Notes: There was no statistical difference between the age of males and females. Regarding the mean total score of the HDRS, females had statistically significant 
higher scores than males. Patient assessment using SCID revealed no significant difference between males and females. ESS, AHI, lowest O2 saturation, and arousal index 
showed no statistically significant difference between males and females. aMild depression = major depressive episode, mild; bmod depression = major depressive episode, 
moderate; *significant.
Abbreviations: Ahi, apnea-hypopnea index; DF, degree of freedom; ESS, Epworth Sleepiness Score; hDrS, hamilton Depression rating Scale; SciD, Structured clinical 
interview for Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition.Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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use of the CPAP, no longer met the diagnostic criteria needed 
for the diagnosis of a depressive episode after CPAP use 
and only five patients met the diagnosis of a mild depressive 
  episode. The ESS scores decreased from a mean of 11.6 ± 8.6 
to 5.1 ± 3.1 and this difference was statistically significant 
(t = 7.6, P = 0.000). ESS scores showed a significant posi-
tive correlation with HDRS after the use of CPAP (r = 0.7, 
P = 0.000).
The changes in individual symptoms on HDRS after the 
use of CPAP are given in Table 4; the scores for most of 
the items on HDRS decreased significantly. In addition, a 
separate analysis for HDRS scores was conducted, excluding 
four items: three concerned with sleep and one with fatigue. 
The aim was to determine the change in the HDRS scores 
when removing symptoms that could be caused by sleep 
apnea itself (Table 5).
Discussion
In this study, it was aimed to determine the rate of depressive 
symptoms associated with OSA, and the relation between dif-
ferent variables of sleep apnea with depression, as well as to 
study the effect of CPAP on the psychological well-being of 
these patients. Over a period of 6 months, the number of male 
patients referred for assessment for possible OSA was nearly 
twice that of females (24 males compared with 13 females). 
This discrepancy might reflect the increased incidence of 
OSA in males reported in several studies26,27 but could also 
be due to bias in referral with more male patients referred 
for the sleep study. In the current study, the main aim was 
not to determine the prevalence of the disorder in a specific 
population but rather to study the association between OSA 
and depression.
More than half of the studied sample (56.7%) had 
depressive symptoms as measured by HDRS; eight of 
these patients (21.6%) had clinically significant moderate 
to severe symptoms. This high prevalence is in line with 
findings reported in some studies in which OSA was highly 
associated with depression.6–8 Females showed a higher rate 
of depression although this difference was not statistically 
significant; females had statistically higher scores than 
males on the HDRS, and this finding has been reported in 
previous studies.9,15 When using the SCID to establish a 
DSM-IV diagnosis, the total number of individuals with 
a clinical diagnosis of depressive disorder was eleven 
(29.7%), and there was no statistically significant difference 
between females and males in the rate of occurrence of 
depressive disorders using this method. From the above, it 
can be concluded that the prevalence of depression in the 
same sample varied according to the tool used, with a high 
prevalence when measured with the HDRS, a tool used 
mainly to measure the severity of depressive symptoms 
rather than to generate a diagnosis. This finding can 
explain some of the differences in the rate of depression 
in individuals with OSA found across different studies.2–5 
It can also be concluded that the main difference between 
females and males might be in the degree of severity of 
depressive symptoms rather than the mere prevalence of 
depression in individuals with OSA.
Table 2 correlation studies at initial assessment
HDRS AHI ESS Lowest SaO2
Age r = 0.25, P = 0.1 r = 0.6, P = 0.000* r = 0.4, P = 0.02* r = 0.3, P = 0.048*
Arousal index r = 0.04, P = 0.4 r = 0.06, P = 0.5 r = 0.07, P = 0.6 r = 0.05, P = 0.7
Lowest oxygen saturation r = –0.8, P = 0.000* r = –0.8, P = 0.000* r = –0.7, P = 0.000*
ESS r = 0.9, P = 0.000* r = 0.9, P = 0.000*
Ahi r = 0.7, P = 0.000*
Note: *Significant.
Abbreviations: Ahi, apnea-hypopnea index; ESS, Epworth Sleepiness Scale; hDrS, hamilton Depression rating Scale.
Table 3 comparison between patients on hDrS before and after cPAP treatment
Individuals (N) HDRS at baseline HDRS at follow-up Differences
Mild 13 Mean 11.9 ± 0.8 Mean 7 ± 1.9 t = 11.8, DF 12, P = 0.000*
Moderate 4 Mean 15.7 ± 0.9 Mean 11.4 ± 0.9 t = 4.3, DF 3, P = 0.02*
Severe 4 Mean 35.5 ± 3.5 Mean 27.2 ± 3.4 t = 3, DF 3, P = 0.047*
Total 21 Mean 11.5 ± 9.6 Mean 7.4 ± 7.8 t = 8.6, DF 36, P = 0.000*
Normal 16 Mean 4.3 ± 2.5 Mean 1.8 ± 1 t = 5, DF 15, P = 0.000*
Note: *Significant.
Abbreviations: cPAP, continuous positive airway pressure; DF, degree of freedom; hDrS, hamilton Depression rating Scale.Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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Table 4 changes in individual symptoms on hDrS after cPAP use
Before CPAP (baseline) After CPAP Difference
Depressed mood Mean = 1.7, SD 1.1 Mean = 1, SD 0.7 t = 6.9, DF = 36, P = 0.000
Feeling of guilt Mean = 0.7, SD 0.9 Mean = 0.5, SD 0.6 t = 3.2, DF = 36, P = 0.000
Suicide Mean = 0.2, SD 0.5 Mean = 0.1, SD 0.3 t = 1.7, DF = 36, P = 0.08
Work and activities Mean = 1.3, SD 1.1 Mean = 0.9, SD 0.8 t = 4.9, DF = 36, P = 0.000
retardation Mean = 0.7, SD 0.9 Mean = 0.5, SD 0.8 t = 2.3, DF = 36, P = 0.02
Agitation Mean = 0, SD Mean = 0, SD Not calculated
Anxiety – psychic Mean = 0.5, SD 1.1 Mean = 0.4, SD 0.9 t = 1.6, DF = 36, P = 0.1
Anxiety – somatic Mean = 0.4, SD 0.9 Mean = 0.3, SD 0.8 t = 2, DF = 36, P = 0.04
Somatic symptoms – gi Mean = 0.1, SD 0.5 Mean = 0.1, SD 0.5 Not calculated
genital symptoms Mean = 0.5, SD 0.7 Mean = 0.2, SD 0.6 t = 3.1, DF = 36, P = 0.003
hypochondrias Mean = 0.3, SD 0.7 Mean = 0.1, SD 0.5 t = 1.9, DF = 36, P = 0.05
Weight loss Mean = 0.6, SD 0.6 Mean = 0.5, SD 0.6 t = 3.1, DF = 36, P = 0.003
insight Mean = 0, SD Mean = 0, SD Not calculated
insomnia – early Mean = 0.7, SD 0.7 Mean = 0.5, SD 0.5 t = 2.5, DF = 36, P = 0.01
insomnia – middle Mean = 1.3, SD 0.5 Mean = 0.7, SD 0.6 t = 6, DF = 36, P = 0.000
insomnia – late Mean = 0.5, SD 0.6 Mean = 0.2, SD 0.5 t = 3.4, DF = 36, P = 0.002
Somatic symptom general (fatigue) Mean = 1.5, SD 0.6 Mean = 0.9, SD 0.6 t = 6.7, DF = 36, P = 0.000
Note: *Statistically significant (P # 0.05).
Abbreviations: cPAP, continuous positive airway pressure; DF, degree of freedom; hDrS, hamilton Depression rating Scale.
Table 5 hDrS scores after removal of sleep and fatigue symptoms
Baseline After CPAP Difference
hDrS total score Mean = 11.5, SD 9.6 Mean = 7.5, SD 7.8 t = 8.6, DF = 36, P = 0.000
hDrS score omitting fatigue and insomnia Mean = 7.4, SD 8 Mean = 5, SD 6.5 t = 6.6, DF = 36, P = 0.000
Difference t = 13.1, DF = 36, P = 0.000 t = 8.7, DF = 36, P = 0.000 –
Note: *Statistically significant (P # 0.05).
Abbreviations: cPAP, continuous positive airway pressure; DF, degree of freedom; hDrS, hamilton Depression rating Scale.
There was a significant negative correlation between 
lowest oxygen saturation and HDRS scores. This finding 
was reported by Means et al,28 but McCall et al15 reported 
the inverse relation for females with OSA; the difference 
between the present authors’ results and their results might 
be due to gender differences of the examined   population. 
A positive correlation was found between daytime 
  sleepiness – as measured by the ESS – and HDRS, and this 
finding has been reported in some studies.16,29 The AHI was 
correlated positively with the HDRS scores and this finding 
has also been reported by some studies,6,15 although Dominici 
and Gomes18 did not find such a relation. The difference in 
reported results might be due to methodological differences, 
particularly the use of a different tool to assess depression – 
the Beck Depression Inventory – with a different cut-off 
point and different variables assessed. Thus, the severity of 
depression was correlated with components of OSA and this 
finding adds to the hypothesis that a causal relation might 
exist between the two disorders.
At follow-up, marked improvement of depression was 
found after the use of CPAP, as reflected by statistically 
significant improvement on the HDRS. In addition, only 
five patients of those diagnosed with the SCID as having a 
depressive disorder still met the DSM-IV diagnostic criteria 
for a depressive episode after CPAP treatment. These patients 
might require specific antidepressant treatment whereas the 
remaining six patients would not require additional treatment 
with CPAP. Most studies showed improvement of depressive 
symptoms with the use of the CPAP,6,19,20 and this finding is 
replicated in the current study, but some studies21,22 found 
no improvement in depression after CPAP use. In the first 
study,21 only individuals with severe OSA were included and 
the second study included a limited number of patients.22 
The difference in results might also be due to differences in 
the tool used and cut-off points taken and this is clear in the 
current study. When HDRS was used as the tool to assess 
depression severity the improvement after CPAP use was very 
obvious but, when SCID was used, improvement was less 
obvious. In addition, when the scores for symptoms of fatigue 
and insomnia, which can be caused by OSA, were removed 
and then the total scores of the HDRS were calculated, the 
scores significantly dropped. Thus tools may vary in their Neuropsychiatric Disease and Treatment 2011:7 submit your manuscript | www.dovepress.com
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ability to detect changes in depressive symptoms according 
to the items screened by that tool which may account for 
some differences reported in different studies.2–5
In the current study, a statistically significant correlation 
between ESS score and HDRS scores on follow-up indicated 
that as daytime sleepiness improves, depression improves. 
This finding has been reported in previous studies30,31 and 
supports the hypothesis that sleep fragmentation and daytime 
sleepiness might have an important role in the generation of 
depression in these individuals.
Analysis of individual symptoms on HDRS showed statis-
tically significant improvement in core depressive symptoms 
after CPAP use; this indicates a favorable effect of CPAP on 
depressive symptoms. The authors of the present study also 
conducted analysis comparing the total HDRS score with the 
total score after removing the scores of four items concern-
ing insomnia and fatigue, which could be caused by sleep 
apnea itself (Table 5). The results of this analysis showed 
statistically significant differences between the two scores 
with a marked decrease in scores after removal of these four 
symptoms.   However, changes occurring in both scores after 
using the CPAP remained statistically significant. Depres-
sion in OSA can be overdiagnosed using tools to screen for 
depression. However, changes in depressive psychopathology 
after CPAP use can still be detected by these instruments in 
patients with OSA.
This study has its own limitations, particularly the lim-
ited number of patients included and the unequal number of 
males and females.
In conclusion, depression was prevalent in individuals 
with OSA and was more severe in females. In addition, 
depression was highly correlated with variables of OSA, 
and improvement in OSA with the use of CPAP was asso-
ciated with improvement in severity of depression. Careful 
assessment for OSA in patients presenting with depressive 
symptoms is important to avoid unnecessary use of antide-
pressant medications because a large subset of those patients 
will improve clinically using the CPAP only.
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